Palisade Bio, Inc. Share Price
NASDAQ: PALI | Micro CapPalisade Bio, Inc. Stock Performance
Palisade Bio, Inc. Share Price Today
As of 9 October 2026, Palisade Bio, Inc.'s share price is $1.46. The stock opened at $1.47, compared to its previous close of $1.48. During today's trading session, Palisade Bio, Inc.'s share price traded between $1.39 and $1.47, with an average price of $1.43. Over the past 52 weeks, the stock has recorded a high of $2.85 and a low of $1.32. In terms of performance, Palisade Bio, Inc.'s share price has declined by 26.88% over the last six months and is down 29.37% on a year-on-year basis.
Palisade Bio, Inc. Share Price Chart
Palisade Bio, Inc. Quarterly Profit & Loss
All figures in USD
Palisade Bio, Inc. Annual Profit & Loss
All figures in USD
About Palisade Bio, Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Palisade Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.37 | $1.46 | +9.36% |
Sep 2026 | $1.98 | $1.33 | -36.73% |
Aug 2026 | $1.90 | $2.11 | +11.35% |
Jul 2026 | $2.13 | $1.90 | -10.19% |
Jun 2026 | $2.12 | $2.11 | -0.94% |
May 2026 | $1.97 | $2.13 | +7.04% |
Apr 2026 | $1.76 | $1.99 | +13.71% |
Mar 2026 | $1.75 | $1.75 | -1.41% |
Feb 2026 | $1.49 | $1.77 | +18.33% |
Jan 2026 | $2.40 | $1.50 | -36.44% |
Dec 2025 | $2.03 | $2.36 | +12.11% |
Nov 2025 | $1.99 | $2.10 | +2.18% |